Cancer de la prostate Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer 15 février 2022
Cancer de la prostate Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21). 18 septembre 2021
Cancer de la prostate Validation of Cell-Free RNA and Circulating Tumor Cells for Molecular Marker Analysis in Metastatic Prostate Cancer 12 août 2021
Cancer de la prostate Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer 21 avril 2021
Cancer de la prostate Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer 28 octobre 2020
Cancer de la prostate Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level 8 août 2020
Cancer de la prostate Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations 16 avril 2020
Cancer de la prostate Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy 14 août 2019
Cancer de la prostate Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients 20 juin 2019
Cancer de la prostate Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups 12 février 2017
